Early hyperglycemia may influence cancer risk after type 2 diabetes diagnosis. See what a large cohort study found about early glycemic exposure.
Read More »A1C Has a Blind Spot: Could Glycated Albumin Help Clinicians Act Faster?
A1C is one of the most useful tools in diabetes care, but it has an important limitation: it takes time to reflect change. Could a faster-moving marker help clinicians know sooner whether treatment is working? New randomized research on glycated albumin in diabetes offers an intriguing answer. Glycated albumin reflects …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.